共 256 条
[1]
Malakar A.K.(2019)A review on coronary artery disease, its risk factors, and therapeutics J. Cell Physiol 234 16812-16823
[2]
Choudhury D.(2020)Drug discovery for coronary artery disease Adv. Exp. Med. Biol 1177 297-339
[3]
Halder B.(2009)2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the International society for heart and lung transplantation J. Am. Coll. Cardiol 53 e1-e90
[4]
Paul P.(2022)Biomarkers for non-invasive stratification of coronary artery disease and prognostic impact on long-term survival in patients with stable coronary heart disease Nutrients 14 3433-30
[5]
Uddin A.(2020)Novel invasive and noninvasive cardiac-specific biomarkers in obesity and cardiovascular diseases Metab. Syndr. Relat. Disord 18 10-2716
[6]
Chakraborty S.(2018)Non-coding RNAs in cardiovascular diseases: Diagnostic and therapeutic perspectives Eur. Heart J. 39 2704-347
[7]
Wan Q.(2019)Assessment of micro ribonucleic acids after exercise: Is this the future to detect coronary artery disease at its early stage? Eur. J. Prev. Cardiol 26 346-583
[8]
Qian S.(2019)Long noncoding RNA-MEG3 contributes to myocardial ischemia-reperfusion injury through suppression of MIR-7-5p expression Biosci. Rep 39 BSR20190210-3335
[9]
Huang Y.(2017)Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction Circ. Res 121 575-7447
[10]
Zhang Y.(2019)STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis Sci. Rep 9 460-251